Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

An open label trial of anakinra to prevent respiratory failure in COVID-19

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cortical signatures of precision grip force control in children, adolescents, and adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Modeling transfer of vaginal microbiota from mother to infant in early life

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Host-induced spermidine production in motile Pseudomonas aeruginosa triggers phagocytic uptake

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Linking Stressful Life Events and Chronic Inflammation Using suPAR (Soluble Urokinase Plasminogen Activator Receptor)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Evdoxia Kyriazopoulou
  • Periklis Panagopoulos
  • Symeon Metallidis
  • George N Dalekos
  • Garyphallia Poulakou
  • Nikolaos Gatselis
  • Eleni Karakike
  • Maria Saridaki
  • Georgia Loli
  • Aggelos Stefos
  • Danai Prasianaki
  • Sarah Georgiadou
  • Olga Tsachouridou
  • Vasileios Petrakis
  • Konstantinos Tsiakos
  • Maria Kosmidou
  • Vassiliki Lygoura
  • Maria Dareioti
  • Haralampos Milionis
  • Ilias C Papanikolaou
  • Karolina Akinosoglou
  • Dimitra-Melia Myrodia
  • Areti Gravvani
  • Aliki Stamou
  • Theologia Gkavogianni
  • Konstantina Katrini
  • Theodoros Marantos
  • Ioannis P Trontzas
  • Konstantinos Syrigos
  • Loukas Chatzis
  • Stamatios Chatzis
  • Nikolaos Vechlidis
  • Christina Avgoustou
  • Stamatios Chalvatzis
  • Miltiades Kyprianou
  • Jos Wm van der Meer
  • Jesper Eugen-Olsen
  • Mihai G Netea
  • Evangelos J Giamarellos-Bourboulis
Vis graf over relationer

Background: It was studied if early suPAR-guided anakinra treatment can prevent severe respiratory failure (SRF) of COVID-19.

Methods: A total of 130 patients with suPAR ≥6 ng/ml were assigned to subcutaneous anakinra 100 mg once daily for 10 days. Primary outcome was SRF incidence by day 14 defined as any respiratory ratio below 150 mmHg necessitating mechanical or non-invasive ventilation. Main secondary outcomes were 30-day mortality and inflammatory mediators; 28-day WHO-CPS was explored. Propensity-matched standard-of care comparators were studied.

Results: 22.3% with anakinra treatment and 59.2% comparators (hazard ratio, 0.30; 95% CI, 0.20-0.46) progressed into SRF; 30-day mortality was 11.5% and 22.3% respectively (hazard ratio 0.49; 95% CI 0.25-0.97). Anakinra was associated with decrease in circulating interleukin (IL)-6, sCD163 and sIL2-R; IL-10/IL-6 ratio on day 7 was inversely associated with SOFA score; patients were allocated to less severe WHO-CPS strata.

Conclusions: Early suPAR-guided anakinra decreased SRF and restored the pro-/anti-inflammatory balance.

Funding: This study was funded by the Hellenic Institute for the Study of Sepsis, Technomar Shipping Inc, Swedish Orphan Biovitrum, and the Horizon 2020 Framework Programme.

Clinical trial number: NCT04357366.

OriginalsprogEngelsk
Artikelnummere66125
TidsskrifteLife
Vol/bind10
Sider (fra-til)1-21
Antal sider21
ISSN2050-084X
DOI
StatusUdgivet - 8 mar. 2021

ID: 64083353